Literature DB >> 29569211

Recommendations for urological follow-up of patients with neurogenic bladder secondary to spinal cord injury.

Mikolaj Przydacz1,2, Piotr Chlosta2, Jacques Corcos3.   

Abstract

PURPOSE: To review currently available guidelines and recommendations regarding urological follow-up of patients after spinal cord injury (SCI) and present an evidence-based summary to support clinicians in their clinical practice.
METHODS: Maximum data were collected according to different methods, including searches with multiple and specific keywords, reference checks, gray literature searches (congress reports, working papers, statement documents), and browsing-related Web site access. Obtained data were analyzed with the modified version of the Oxford grading system for recommendations using levels of evidence (LE) and grades of recommendation (GR).
RESULTS: Different surveillance strategies exist, but there is no consensus among authors and organizations. As a result, practice patterns vary around the world. The present review indicates that proper urological follow-up of SCI patients should consist of medical history (LE 1-4, GR B-C), clinical examination (LE 4, GR C), renal laboratory tests (LE 1-3, GR B), imaging surveillance of the upper urinary tract (LE 1-3, GR A-B), urodynamic study (LE 2-4, GR B-C), and cystoscopy/cytology (LE 1-4, GR D). Clinicians agree that SCI patients should be followed up regularly with an individually tailored approach. A 1-year follow-up schedule seems reasonable in SCI patients without additional risk factors of renal deterioration (LE 3-4, GR C). In those who manifest risk factors, report changes in bladder behavior, or present with already developed complications of neurogenic bladder dysfunction, follow-up plans should be modified with more frequent checkups (LE 4, GR C). Urodynamic study should be repeated and considered as a routine monitoring strategy.
CONCLUSION: Individuals with neurogenic lower urinary tract dysfunction are at increased risk of multiple complications. Nevertheless, proper follow-up after SCI improves the prognosis for these patients and their quality of life.

Entities:  

Keywords:  Follow-up; Monitoring; Neurogenic bladder; Neurogenic lower urinary tract dysfunction; Spinal cord injury

Mesh:

Year:  2018        PMID: 29569211     DOI: 10.1007/s11255-018-1852-7

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  83 in total

Review 1.  Systematic review of urological followup after spinal cord injury.

Authors:  Anne P Cameron; Gianna M Rodriguez; Katherine G Schomer
Journal:  J Urol       Date:  2011-12-15       Impact factor: 7.450

2.  Bacteriuria in patients treated with clean intermittent catheterization.

Authors:  A Bakke; A Digranes
Journal:  Scand J Infect Dis       Date:  1991

Review 3.  Neurogenic lower urinary tract dysfunction: how, when, and with which patients do we use urodynamics?

Authors:  Teresa L Danforth; David A Ginsberg
Journal:  Urol Clin North Am       Date:  2014-05-22       Impact factor: 2.241

4.  Prediction of creatinine clearance from serum creatinine in spinal cord injury patients.

Authors:  M K Mirahmadi; C Byrne; C Barton; N Penera; S Gordon; N D Vaziri
Journal:  Paraplegia       Date:  1983-02

5.  Role of creatinine clearance as a screening test in persons with spinal cord injury.

Authors:  Farhad Sepahpanah; Stephen P Burns; Barbara McKnight; Claire C Yang
Journal:  Arch Phys Med Rehabil       Date:  2006-04       Impact factor: 3.966

Review 6.  Neurogenic detrusor overactivity in patients with spinal cord injury: evaluation and management.

Authors:  Arun Sahai; Eduardo Cortes; Jai Seth; Muhammad Shamim Khan; Jalesh Panicker; Cornelius Kelleher; Thomas M Kessler; Clare J Fowler; Prokar Dasgupta
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

Review 7.  Bladder cancer in individuals with spinal cord injuries.

Authors:  B Welk; A McIntyre; R Teasell; P Potter; E Loh
Journal:  Spinal Cord       Date:  2013-04-23       Impact factor: 2.772

8.  Bladder cancer in spinal cord injury patients.

Authors:  J F Kalisvaart; H K Katsumi; L D Ronningen; R M Hovey
Journal:  Spinal Cord       Date:  2009-09-15       Impact factor: 2.772

9.  Predictive criteria for failed sphincterotomy in spinal cord injury patients.

Authors:  J K Light; A Beric; P G Wise
Journal:  J Urol       Date:  1987-11       Impact factor: 7.450

10.  The use of urologic investigations among patients with traumatic spinal cord injuries.

Authors:  Blayne Welk; Kuan Liu; Salimah Z Shariff
Journal:  Res Rep Urol       Date:  2016-02-22
View more
  10 in total

1.  Letter to the editor.

Authors:  Michael S Floyd; Rauf N Khadr
Journal:  Int Urol Nephrol       Date:  2018-07-25       Impact factor: 2.370

2.  Response to the Letter to the editor.

Authors:  Mikolaj Przydacz; Piotr Chlosta; Jacques Corcos
Journal:  Int Urol Nephrol       Date:  2018-08-02       Impact factor: 2.370

3.  Expression profiles of long non-coding RNAs in neurogenic bladder of spinal cord injured rats: a transcriptomic analysis.

Authors:  Jimeng Ruan; Zhenhua Shang; Hao Yan; Bo Cui; Qi Wang; Jiangtao Wu; Chunsong Jia; Xin Cui; Jin Li; Tongwen Ou
Journal:  Transl Androl Urol       Date:  2022-06

4.  A Primary Care Provider's Guide to Preventive Health After Spinal Cord Injury.

Authors:  James Milligan; Stephen Burns; Suzanne Groah; Jeremy Howcroft
Journal:  Top Spinal Cord Inj Rehabil       Date:  2020

5.  MicroRNA expression profile in the spinal cord injured rat neurogenic bladder by next-generation sequencing.

Authors:  Zhenhua Shang; Tongwen Ou; Jianjun Xu; Hao Yan; Bo Cui; Qi Wang; Jiangtao Wu; Chunsong Jia; Xin Cui; Jin Li
Journal:  Transl Androl Urol       Date:  2020-08

6.  Evaluation and management of neurogenic bladder after spinal cord injury: Current practice among physical medicine and rehabilitation specialists in Turkey.

Authors:  Yeşim Akkoç; Murat Ersöz; Ece Çınar; Haydar Gök
Journal:  Turk J Phys Med Rehabil       Date:  2021-05-25

7.  Telmisartan inhibits bladder smooth muscle fibrosis in neurogenic bladder rats.

Authors:  Qian Liu; Ruoyi Wang; Nan Ma; Chuntian Wang; Weixiu Chen
Journal:  Exp Ther Med       Date:  2022-01-11       Impact factor: 2.447

8.  Population-Based Study of Prevalence, Bother and Behavior Related to Treatment for Lower Urinary Tract Symptoms and Overactive Bladder among Polish Neurogenic Patients.

Authors:  Mikolaj Przydacz; Marcin Chlosta; Tomasz Golabek; Piotr Chlosta
Journal:  Brain Sci       Date:  2021-05-27

9.  Urine retention as the first presentation of congenital absence of the sacrum: A case report of a rare clinical phenomenon.

Authors:  Hongzeng Wu; Peng Qi; Ruoheng Dai; Ze Li; Helin Feng
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

10.  Botulinum toxin A improves neurogenic bladder fibrosis by suppressing transforming growth factor β1 expression in rats.

Authors:  Chunsong Jia; Tianying Xing; Zhenhua Shang; Xin Cui; Qi Wang; Tongwen Ou
Journal:  Transl Androl Urol       Date:  2021-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.